Dydrogesterone is an eligible tool to suppress LH surge in assisted reproduction technologies (ART) cycles. [PDF]
Souza MM +8 more
europepmc +1 more source
Why does the latest pharmacovigilance data not reflect clinical experience with dydrogesterone? [PDF]
Pabuccu E +4 more
europepmc +1 more source
The Impact of Cleavage and Blastocyst Stage Sequential Transfer on Clinical Pregnancy Outcomes of Frozen Embryo Transfer in Patients with Multiple Transplant Failures: A Retrospective Cohort Study. [PDF]
Huang C +6 more
europepmc +1 more source
Efficacy of estradiol-dydrogesterone and auto-crosslinked hyaluronan gel in preventing intrauterine adhesions following missed miscarriage curettage: a retrospective observational study. [PDF]
Sheng H, Sui M, Zhang L, Shi J, Xue L.
europepmc +1 more source
Live birth rates are unrelated to sex-steroid levels on ET day in a dydrogesterone-based 'programmed-ovulatory FET' protocol: a multi-centric prospective cohort study. [PDF]
Eggersmann TK +13 more
europepmc +1 more source
A novel fertility-sparing nanocomposite for endometriosis treatment via oxidative stress and inflammation alleviation. [PDF]
Liu W +10 more
europepmc +1 more source
Correction to: Pregnancy and perinatal outcomes after modified natural cycle-frozen embryo transfers according to size of the dominant follicle on the hCG trigger day. [PDF]
europepmc +1 more source
Analysis of Menopausal Hormone Therapy to Chinese Patients with Menopausal Syndrome: A Real-World Retrospective Study from Chinese Hospitals. [PDF]
Zhu Z, Shi A, Liu L, Jin G, Wang X.
europepmc +1 more source
Oral Dydrogesterone Versus Vaginal Progesterone for Luteal Phase Support in Frozen-Thawed Embryo Transfer Cycles: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. [PDF]
Stavridis K +6 more
europepmc +1 more source
Reply: Fetal safety of dydrogesterone: clarifying the role of pharmacovigilance. [PDF]
Chouchana L +7 more
europepmc +1 more source

